Ching Lau, M.D., Ph.D.
Professor
Ching Lau's clinical interests include neuro-oncology, solid tumors, and osteosarcoma.
Ching Lau serves as the Medical Director of Hematology-Oncology at Connecticut Children’s, as Professor at JAX where he specializes in pediatric brain and bone tumor research, and as Head of the Division of Pediatric Hematology-Oncology in the Department of Pediatrics at the UConn School of Medicine. His clinical interests include neuro-oncology, solid tumors, and osteosarcoma.
-
Research HighlightNovember 10, 2020Pediatric brain cancer research reveals the potential for precision therapies
Cancer researchers have identified the enhanced expression of many signaling pathways implicated in cancer initiation and maintenance. -
Press ReleaseOctober 24, 2018
Data provides new hope for pediatric brain tumor patients
Using computer models, researchers have identified a potential new therapy that would reduce the long-term side effects of radiation therapy in pediatric brain cancer patients. -
Press ReleaseOctober 07, 2016Leading oncologist and cancer researcher Ching Lau joins JAX faculty
Joint appointment with Connecticut Children's Medical Center and the UConn School of Medicine will foster development of new genomic technologies for pediatric brain and bone cancers, create advanced treatments for patients.
-
Search MagazineMarch 06, 2019Finding a better way to fight childhood cancers
Ching Lau is working to find effective therapies and test them against patients’ own tumors in specially made patient derived xenotype (PDX) mice. -
Blog PostFebruary 07, 2017Connecticut's bioscience push lands top worldwide talent
The Hartford Business Journal reports on how Connecticut's bioscience push is attracting some of the top scientific minds in the world.